Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015)

Collegium Pharmaceutical has reported Preferred Stock Liabilities for 2 years, with the latest figure at $50.4 million in Q1 2015.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $50.4 million in Q1 2015; TTM through Mar 2015 was $50.4 million, a N/A change from a year earlier, with the FY2014 full-year figure at $51.2 million, up 3.72% from the prior year.
• Preferred Stock Liabilities was $50.4 million for Q1 2015 at Collegium Pharmaceutical, down from $51.2 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $51.2 million in Q4 2014, with the low at $50.4 million in Q1 2015.